FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Kazuyuki Hashimoto

Research Profile

Chemicals & Drugs

Living Beings

Mouse
Rats

Concepts & Ideas

Tissue Distribution

Disorders

Phenomena

Metabolic Clearance Rate

Physiology

Organ Specificity

Procedures

Anatomy

Microvilli

Co-author Network

Publications

TOP 3
Kazuma Ogawa; Takahiro Mukai; Keiichi Kawai; Norito Takamura; Hirofumi Hanaoka; Kazuyuki Hashimoto; Kazuhiro Shiba; Hirofumi Mori; Hideo Saji
Usefulness of competitive inhibitors of protein binding for improving the pharmacokinetics of 186Re-MAG3-conjugated bisphosphonate (186Re-MAG3-HBP), an agent for treatment of painful bone metastases.
Tomoya Uehara; Miho Koike; Hideo Nakata; Hirofumi Hanaoka; Yasuhiko Iida; Kazuyuki Hashimoto; Hiromichi Akizawa; Keigo Endo; Yasushi Arano
Design, synthesis, and evaluation of [188Re]organorhenium-labeled antibody fragments with renal enzyme-cleavable linkage for low renal radioactivity levels.
Tomoya Uehara; Zhe-Long Jin; Kazuma Ogawa; Hiromichi Akizawa; Kazuyuki Hashimoto; Morio Nakayama; Yasushi Arano
Assessment of 186Re chelate-conjugated bisphosphonate for the development of new radiopharmaceuticals for bones.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Kazuyuki Hashimoto (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Kazuma Ogawa; Takahiro Mukai; Keiichi Kawai; Norito Takamura; Hirofumi Hanaoka; Kazuyuki Hashimoto; Kazuhiro Shiba; Hirofumi Mori; Hideo Saji
Usefulness of competitive inhibitors of protein binding for improving the pharmacokinetics of 186Re-MAG3-conjugated bisphosphonate (186Re-MAG3-HBP), an agent for treatment of painful bone metastases.
European journal of nuclear medicine and molecular imaging 2009;36(1):115-21.
2007: Tomoya Uehara; Miho Koike; Hideo Nakata; Hirofumi Hanaoka; Yasuhiko Iida; Kazuyuki Hashimoto; Hiromichi Akizawa; Keigo Endo; Yasushi Arano
Design, synthesis, and evaluation of [188Re]organorhenium-labeled antibody fragments with renal enzyme-cleavable linkage for low renal radioactivity levels.
Bioconjugate chemistry 2007;18(1):190-8.
2007: Tomoya Uehara; Zhe-Long Jin; Kazuma Ogawa; Hiromichi Akizawa; Kazuyuki Hashimoto; Morio Nakayama; Yasushi Arano
Assessment of 186Re chelate-conjugated bisphosphonate for the development of new radiopharmaceuticals for bones.
Nuclear medicine and biology 2007;34(1):79-87.
2007: Kazuma Ogawa; Takahiro Mukai; Daigo Asano; Hidekazu Kawashima; Seigo Kinuya; Kazuhiro Shiba; Kazuyuki Hashimoto; Hirofumi Mori; Hideo Saji
Therapeutic effects of a 186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(1):122-7.
2006: Kazuma Ogawa; Takahiro Mukai; Yasushi Arano; Akira Otaka; Masashi Ueda; Tomoya Uehara; Yasuhiro Magata; Kazuyuki Hashimoto; Hideo Saji
Rhemium-186-monoaminemonoamidedithiol-conjugated bisphosphonate derivatives for bone pain palliation.
Nuclear medicine and biology 2006;33(4):513-20.
2005: Kazuma Ogawa; Takahiro Mukai; Yasushi Arano; Masahiro Ono; Hirofumi Hanaoka; Seigo Ishino; Kazuyuki Hashimoto; Hiroshi Nishimura; Hideo Saji
Development of a rhenium-186-labeled MAG3-conjugated bisphosphonate for the palliation of metastatic bone pain based on the concept of bifunctional radiopharmaceuticals.
Bioconjugate chemistry 2005;16(4):751-7.
2003: Tomoya Uehara; Miho Koike; Hideo Nakata; Shigehiko Miyamoto; Shoji Motoishi; Kazuyuki Hashimoto; Naoto Oku; Morio Nakayama; Yasushi Arano
In vivo recognition of cyclopentadienyltricarbonylrhenium (CpTR) derivatives.
Nuclear medicine and biology 2003;30(3):327-34.